238 related articles for article (PubMed ID: 28962887)
1. A Population-Based Cohort Study on the Drug-Specific Effect of Statins on Sepsis Outcome.
Lee CC; Lee MG; Hsu TC; Porta L; Chang SS; Yo CH; Tsai KC; Lee M
Chest; 2018 Apr; 153(4):805-815. PubMed ID: 28962887
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.
Milner E; Ainsworth M; Gleaton M; Bookstaver D
J Clin Pharm Ther; 2022 May; 47(5):668-675. PubMed ID: 35032137
[TBL] [Abstract][Full Text] [Related]
3. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
[TBL] [Abstract][Full Text] [Related]
4. Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis.
Minard LV; Corkum A; Sketris I; Fisher J; Zhang Y; Saleh A
PLoS One; 2016; 11(7):e0158608. PubMed ID: 27434392
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome.
Bener A; Dogan M; Barakat L; Al-Hamaq AO
J Prim Care Community Health; 2014 Jul; 5(3):180-7. PubMed ID: 24522932
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
7. Effect of the use of low and high potency statins and sepsis outcomes.
Ou SY; Chu H; Chao PW; Ou SM; Lee YJ; Kuo SC; Li SY; Shih CJ; Chen YT
Intensive Care Med; 2014 Oct; 40(10):1509-17. PubMed ID: 25091791
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].
Cosin Sales J; Fuentes Jiménez FJ; Mantilla Morató T; Ruiz E; Becerra V; Aceituno S; Ferrario MG; Lizán L; Gracia A
Clin Investig Arterioscler; 2015; 27(5):228-38. PubMed ID: 25640158
[TBL] [Abstract][Full Text] [Related]
9. 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan's National Health Insurance Research Database.
Hsieh HC; Hsu JC; Lu CY
BMJ Open; 2017 May; 7(5):e014150. PubMed ID: 28515189
[TBL] [Abstract][Full Text] [Related]
10. Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia.
Sivkov A; Chernus N; Gorenkov R; Sivkov S; Sivkova S; Savina T
Lipids Health Dis; 2021 Nov; 20(1):157. PubMed ID: 34749751
[TBL] [Abstract][Full Text] [Related]
11. Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer.
Huang BZ; Chang JI; Li E; Xiang AH; Wu BU
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040693
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
13. The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study.
Mueller AM; Liakoni E; Schneider C; Burkard T; Jick SS; Krähenbühl S; Meier CR; Spoendlin J
J Gen Intern Med; 2021 Sep; 36(9):2639-2647. PubMed ID: 33751411
[TBL] [Abstract][Full Text] [Related]
14. Distinct impact of three different statins on arteriovenous fistula outcomes: a retrospective analysis.
Martinez L; Duque JC; Escobar LA; Tabbara M; Asif A; Fayad F; Vazquez-Padron RI; Salman LH
J Vasc Access; 2016 Nov; 17(6):471-476. PubMed ID: 27768209
[TBL] [Abstract][Full Text] [Related]
15. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
Tungsubutra W; Phongtuntakul B
J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
[TBL] [Abstract][Full Text] [Related]
16. Statin use and incident erectile dysfunction--A nationwide propensity-matched cohort study in Taiwan.
Chou CY; Yang YF; Chou YJ; Hu HY; Huang N
Int J Cardiol; 2016 Jan; 202():883-8. PubMed ID: 26476986
[TBL] [Abstract][Full Text] [Related]
17. Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events.
Helin-Salmivaara A; Lavikainen P; Aarnio E; Huupponen R; Korhonen MJ
PLoS One; 2014; 9(3):e90325. PubMed ID: 24614626
[TBL] [Abstract][Full Text] [Related]
18. More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy.
Strutt K; Caplan R; Hutchison H; Dane A; Blasetto J
Circ J; 2004 Feb; 68(2):107-13. PubMed ID: 14745143
[TBL] [Abstract][Full Text] [Related]
19. Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER.
Karlson BW; Wiklund O; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):212-7. PubMed ID: 27533947
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over.
Kwak A; Kim JH; Choi CU; Kim IW; Oh JM; Kim K
Int J Clin Pharm; 2019 Apr; 41(2):460-469. PubMed ID: 30864086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
